Comparing the current results to its competitors, Nexalin Technology Inc reported Revenue decrease in the 2 quarter 2026 year on year by -82.77 %, despite the revenue increase by the most of its competitors of 39.48 %, recorded in the same quarter.
Nexalin Technology Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 34.22 %
Nexalin Technology Inc 's Comment on Competition and Industry Peers
The company addresses market dominance criteria under Article 19, which defines dominant market positions based on market share thresholds. It states that it has not engaged in monopolistic practices in China and that regulatory actions have not impacted its business operations or listings on foreign stock exchanges. The company maintains its competitive position through patents, trademarks, trade secrets, know-how, and technological innovation. It was originally formed as Nexalin Technology, Inc. in Nevada in 2010 and reorganized as a Delaware corporation in 2021.
November 1, 2024
Nexalin Technology Reinstates Nasdaq Compliance with Minimum Bid Price Requirement HOUSTON, TX, November 1, 2024 - In a significant development for its financial standing and market perception, Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW), an innovative leader in neurostimulation technology, has successfully regained compliance with the Nasdaq s minimum bid price requirement as outlined in Nasdaq Rule 5550(a)(2). This announcement follows the Nasdaq Stock Market s formal notice dated October 31, 2024, which signaled a return to good standing after Nexalin navigated the hurdles associated with stock price thresholds.The restoration of compliance is a milestone that underscores Nexalin s commitment to maintai...
Neurocrine Biosciences Inc's business model involves researching, developing, and commercializing innovative therapies for neurological and endocrine disorders.
Sources:
Nexalin Technology Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Nexalin Technology Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
